Use of prescription stimulants doubled from 2006 to 2016 in the United States¹ and, as of 2013, it resulted in more pharmaceutical expenditures for children than any other medication class.² Although the rise in stimulant use parallels increasing attention-deficit/hyperactivity disorder diagnosis rates, stimulants, even when appropriately prescribed, are commonly diverted and used nonmedically.³ It is important to consider factors that may contribute to a potential oversupply of stimulants. Pharmaceutical company marketing is associated with increased prescribing.⁴ The extent to which physicians receive marketing for stimulants is not well described.

中文翻译：

---

2014年至2018年制药行业兴奋剂营销分析。

处方兴奋剂使用从2006年翻番至2016年在美国¹和，截至2013年，它导致了儿童比其他任何药物类的多种药物支出。²尽管兴奋剂使用量的增加与注意力缺陷/多动障碍诊断率的上升同时发生，但即使适当地开具了兴奋剂，也通常会被转移并非医学地使用。³重要的是要考虑可能导致兴奋剂潜在供过于求的因素。制药公司的营销与处方增加有关。⁴医师接受兴奋剂营销的程度没有得到很好的描述。